EUVIMEDEUVIMED entdecken
Crossref

Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain

Tianmiao Li, Han-Shen Tae iD, Shen Chen, Xiao Li, Jiazhen Liang, Teng Pan, Zixuan Zhang, Tao Jiang iD, David J Adams iD, Rilei Yu iD

Journal of Medicinal Chemistry · 2024

DOI: 10.1021/acs.jmedchem.4c00974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2024. Verfasst von Tianmiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266…. Hauptthemen laut MEDLINE: Neuralgia, Conotoxins, Disulfides. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Health and Medical Research Council, Qingdao National Laboratory for Marine Science and Technology, Major Scientific and Technological Innovation Project of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

α-conotoxins (α-Ctxs), a class of disulfide-rich conopetides, are excellent drug leads due to their small size, high selectivity, and potency for specific membrane receptors and ion channels involved in pain transmission. However, their high susceptibility to proteolytic degradation limits their therapeutic potential. In this study, we designed and synthesized a series of conformationally stable analogues of α-Ctx Mr1.1[S4Dap] using various structural optimization strategies. The Mr1.1[S4Dap, C16Pen] analogue maintained potency at human α9α10 nicotinic acetylcholine receptors, with a half-maximal inhibitory concentration (IC50) of 4 nM. It exhibited over a 5-fold increase in serum stability compared to Mr1.1[S4Dap], without disrupting its overall conformation. Furthermore, intravenous application of Mr1.1[S4Dap, C16Pen] showed potent analgesic activity in oxaliplatin-induced cold allodynia, indicating a high potential for drug development. Overall, the results from this study provide valuable insights for optimizing the serum stability of disulfide-rich peptides in future therapeutic applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuralgiaConotoxinsDisulfidesAnimalsHumansReceptors, NicotinicAntineoplastic AgentsMiceMaleOxaliplatinAnalgesicsPeptidesHyperalgesiaAdministration, Intravenous

Substanzen

ConotoxinsDisulfidesReceptors, NicotinicAntineoplastic AgentsOxaliplatinAnalgesicsPeptides

Autor:innen und Institutionen

  • Key Laboratory of Marine Drugs, Chinese Ministry of Education, School of Medicine and Pharmacy, Ocean University of China, 5 Yushan Road, Qingdao 266003, China.
  • Laboratory for Marine Drugs and Bioproducts, Qingdao Marine Science and Technology Center, Qingdao 266237, China.
  • Molecular Horizons, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522, Australia.

ORCID-Profile: Han-Shen Tae, Tao Jiang, David J Adams, Rilei Yu

Förderung

  • National Health and Medical Research Council
  • Qingdao National Laboratory for Marine Science and Technology
  • Major Scientific and Technological Innovation Project of Shandong Province
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • The Jinan Innovation Team Project

Zitieren

APA

Li, T., Tae, H. S., Chen, S., Li, X., Liang, J., Pan, T., Zhang, Z., Jiang, T., Adams, D. J., & Yu, R. (2024). Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c00974

Vancouver

Li T, Tae HS, Chen S, Li X, Liang J, Pan T, et al. Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain. Journal of Medicinal Chemistry. 2024. doi:10.1021/acs.jmedchem.4c00974

BibTeX
@article{Li2024,
  author = {Li, Tianmiao and Tae, Han-Shen and Chen, Shen and Li, Xiao and Liang, Jiazhen and Pan, Teng and Zhang, Zixuan and Jiang, Tao and Adams, David J and Yu, Rilei},
  title = {Development of an Intravenously Stable Disulfide-Rich Peptide for the Treatment of Chemotherapy-Induced Neuropathic Pain},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  doi = {10.1021/acs.jmedchem.4c00974}
}
Kostenlos starten →